Chronic immune stimulation accelerates SIV-induced disease progression

Area of Science:

• Immunology
• Virology
• Pathogenesis

Background:

• Chronic immune stimulation is a hallmark of persistent viral infections like Human Immunodeficiency Virus (HIV).
• The impact of ongoing immune activation on lentivirus disease progression remains incompletely understood.
• The SIVmac251 macaque model closely mimics HIV infection in humans.

Purpose of the Study:

• To investigate the contribution of chronic immune stimulation to the progression of lentivirus-induced disease.
• To evaluate the effect of repeated antigen exposure on survival in SIV-infected macaques.

Main Methods:

• Four macaques were inoculated with SIVmac251 and subsequently received repeated immune stimulations with tetanus toxoid (TT), keyhole limpet hemocyanin (KLH), and allogeneic peripheral blood mononuclear cells (PBMC).
• Survival times of stimulated macaques were compared to those of non-immune-stimulated control macaques infected with the same SIVmac251 stock and dose.
• Plasma viral loads and antibody responses to immunizing antigens were monitored.

Main Results:

• Immune-stimulated macaques exhibited significantly shortened survival (median 9.5 months) compared to control groups (median 17-18 months, P = 0.010 and P = 0.003).
• Accelerated disease progression was not associated with increased plasma viral loads.
• Suboptimal antibody responses to TT and KLH were observed, correlating inversely with survival duration.

Conclusions:

• Chronic immune stimulation significantly accelerates lentivirus-induced disease progression in the SIVmac251 macaque model.
• This accelerated pathogenesis may be linked to impaired adaptive immune responses rather than increased viral replication.
• Findings suggest that managing chronic infectious diseases in HIV-infected individuals could be crucial for disease control.